TruSight Oncology 500 ctDNA training
All three assays in the family are designed to identify key biomarkers in guidelines and clinical trials.
Assess key cancer biomarkers from FFPE tumor tissue with the TruSight Oncology 500 Assay.
Batch up to 192 samples at a time while using the same biomarkers and tissue type as the TruSight Oncology 500 assay.
Analyze circulating tumor DNA from plasma with the TruSight Oncology 500 ctDNA assay.
|Instrument||Recommended Number of Samples||Read Length|
|NovaSeq 6000 System||24 samples per run (S4 flow cell), 800M paired-end reads, 35,000x coverage||2 × 150 bp|
|NovaSeq 6000 System||8 samples per run (S2 flow cell), 800M paired-end reads, 35,000x coverage||2 × 150 bp|
* Based on PierianDx Clinical Genomics Knowledgebase, as of March 2020.
Interpretation & Reporting: